Finally, we validated our in vitro data in formalin-fixed, paraffin-embedded CCM tissue samples of fifteen probands with a pathogenic germline variant in either CCM1, CCM2 or CCM3 and loss of CCM protein expression in the CCM endothelium (Pagenstecher et al., 2009). The gene discussed is CCM2; the disease is cerebral cavernous malformation.